What we do
We build and invest in early-stage medical device companies to help save lives and the planet.
How we do it
We partner with founders to explore new ideas, build exceptional products, and launch world-class companies.
Why we do it
There is $1 trillion+ of unrealized market value sitting in the dusty shelves of university tech transfer offices. There are researchers who want to commercialize their research. There are patients who are in desperate need of cutting-edge technology, providers who want to better serve their patients, and payors who want more cost-effective solutions.
Our thesis is that through identification of the best medical device IP, combined with the finest business minds from around the world, we can build cutting edge medical device companies that will enable patients to live longer, happier and healthier lives.
Themes of interest: Microplastics | Target drug delivery | Tissue & organ regeneration | Non-animal and human clinical trials | Disease predication